Introduction: Diabetes mellitus (DM) is serious healthcare concern in Saudi Arabia, with the disease's prevalence in the country being one of the highest worldwide. This study examines various factors which affect outcomes of patients with DM; namely, medication adherence, diabetes knowledge, self-management behaviours, and glycemic control.
Introduction
Diabetes mellitus (DM) is a fast-growing healthcare problem worldwide, which is now reaching epidemic proportions in some countries. In 2014, it was estimated that almost 422 million people suffered from diabetes, with a global prevalence of 8.5% (World Health Organization [WHO], 2016) . Saudi Arabia is among the 10 countries with highest prevalence of DM worldwide (23.9%; Aguiree et al., 2013) . Many diabetes patients suffer from complications that have a significant impact on their quality of life. In 2012, an estimated 1.5 million deaths were directly caused by diabetes, and higher-than-optimal blood glucose was responsible for an additional 2.2 million deaths due to increased risks of cardiovascular disease and other diseases. This equates to a total of 3.7 million deaths related to blood glucose levels (WHO, 2016) . The WHO expects that diabetes will be the seventh leading cause of death by 2030. This underlines the need to examine the factors which improve outcomes for patients with DM, and in particular, the factors which contribute to improved glycemic control.
into the factors which contribute to poor medication adherence in Saudi Arabia is therefore warranted.
Compliance can also be described as the degree to which patients take an active role in their healthcare self-management. A systematic review (Norris, Engelgau, & Narayan, 2001) found that in studies with a follow up of less than 6 months, self-management training had a positive effect on diabetes knowledge, frequency and accuracy of blood glucose self-monitoring, self-reported dietary habits, and glycemic control. The effect of self-management training on glycemic control is again supported by a study which found that self-management training significantly decreased GHb levels in adults with Type 2 diabetes at immediate follow-up, 1-3 month follow up, and ≥ 4 month follow up when compared to a control group (Norris, Lau, Smith, Schmid, & Engelgau, 2002) .
These findings are in line with the self-determination theory (SDT) of health behaviour change, which posits that the psychological needs of competence and autonomy each contribute to enhanced self-motivation. Changes in perceptions of competence and autonomy have indeed been shown to correlate with changes in glycemic control. Autonomous motivation (behaviour that is conducted through one's own choice rather than through coercion) and perceived competence (the perception that one can control outcomes related to their illness) have both been found to contribute to improved glycemic control (Williams, McGregor, Zeldman, Freedman, & Deci, 2004 ). This suggests that DM patients may benefit from practitioner-driven education that would inform them of their own role in controlling their disease outcomes, as this would increase their autonomous motivation to, and perceived competence in, engaging in self-management behaviours. Indeed, when healthcare providers are more supportive of patient autonomy, patients have higher levels of autonomous motivation and perceived competence, which in turn leads to improvements in their blood glucose levels (Heisler, Smith, Hayward, Krein, & Kerr, 2003; Williams, Freedman, & Deci, 1998) . It is therefore important to consider self-management behaviours as a key determinant of DM patient outcomes.
It is evident from the above examples that practitioner-supported autonomy can increase a patient's perceived competence, and encourage self-management behaviours. For this reason, we also consider patients' diabetes knowledge to play an important role in their healthcare behaviour and outcomes. Al-Qazaz et al. (2011) found an association between patients' diabetes knowledge and medication adherence, with patients who were more knowledgeable about their disease adhering more closely to their treatment regimen than those with poor knowledge. As expected, better diabetes knowledge and medication adherence both correlated with better glycemic control. Furthermore, increases in diabetes knowledge after patients had received diabetes self-management education (DSME) have been shown to predict the achievement of target A1c levels (Berikai et al., 2007) . This is suggestive of a link between self-management behaviours and diabetes knowledge with respect to their effect on glycemic control. While these findings are compelling, it is important to examine the role of medication adherence, self-management behaviours and diabetes knowledge in glycemic control within a Saudi context. Based on a review of the literature, we present the following hypotheses: 1). There is a positive association between diabetes knowledge and medication adherence.
2). There is a positive association between diabetes knowledge and self-management behaviours.
3). There is a positive association between diabetes knowledge and glycemic control. 4). There is a positive association between self-management behaviours and glycemic control.
Methodology

Design
This is a cross-sectional study consisting of interview-based surveys, conducted between February and April 2017. Data were collected in diabetic clinics at King Saud Medical City in Riyadh, Saudi Arabia. Ethical approval was obtained from the Institutional Review Board of Al-Imam Muhammad Ibn Saud Islamic University. This study conforms to the principles of the Helsinki Declaration.
Participants
All participants had a diagnosed case of DM, and had been receiving treatment for at least 6 months prior to enrolment. Patients were excluded if they were not taking medication for diabetes, if they had gestational diabetes, or if they were diagnosed with a psychiatric illness. 512 total participants took part in this study. Participants were aged between 18 and 83 years old (M = 52.45, SD =13.22). 11.3% had a diagnosis of Type 1 diabetes, with 88.7% having Type 2. Mean time since diagnosis was gjhs.ccsenet.org Global Journal of Health Science Vol. 9, No. 12; 2017 27 11.68 years (SD = 9.57). 50.6% of patients used oral hypoglycemic agents as their only form of treatment, while 42.7% used insulin only, and 6.7% used both. See Table 1 for frequencies and Table 2 for descriptive statistics.
Informed consent was obtained from all participants before commencement in this study. 
Measures
To measure medication adherence, the 8-Item Morisky Medication Adherence Scale (MMAS-8) was used. This scale consists of seven yes/no statements, and one Likert-scale question. A high score on this scale indicates poor medication adherence. This scale has been shown to demonstrate both concurrent and predictive validity (Morisky, Green, & Levine, 1986 ).
The Diabetes Self-Management Questionnaire (DSMQ) was used to evaluate self-care activities. This scale has been shown to have good internal consistency, and to correlate significantly with HbA1c levels (Schmitt et al., 2013) . This scale consists of a series of 4-point Likert-scale statements, with a high score indicating a high level of autonomy in the patient's disease management. This scale defines different aspects of self-management through the following subscales: 'Glucose Management', 'Dietary Control', 'Physical Activity', and 'Health-Care Use'.
The revised Diabetes Knowledge Test (DKT2) was used to measure patient's knowledge of diabetes. The test consists of a 14-item test of general diabetes knowledge, and a 9-item test for patients who use insulin as part of their treatment. For the purpose of this study, only the 14-item general test was administered. The DKT2 has been shown to have good internal consistency and validity (Fitzgerald et al., 2016) .
Participants also answered questions about their demographics and treatment. Current blood glucose levels were obtained from patients' medical files. 
Analysis
Data were analysed using correlational and regression analyses, as well as independent samples t-tests. Analyses were performed using IBM SPSS Statistics package, version 24.
Results
Preliminary Analysis
Significant correlations were found between DKT2 score and MMAS8 score, r (488) Apart from fasting glucose levels, the only variable to correlate with HgA1c levels was age, r(490) = -.246, p < .001. See Table 3 for a summary of correlations.
Diabetes Knowledge and Medication Adherence
A regression model with MMAS8 total score and the MMAS8 Likert-scale variable as explanatory variables fit the diabetes knowledge data well, R 2 = .055, F(2, 487) = 14.183, p < .001, with DKT2 scores being significantly explained by the MMAS8. Total score, β = -.157, t(486) = -3.057, p < .01; and the MMAS8 Likert-scale, β = -.112, t(486) = -2.187, p < .05.
Diabetes Knowledge and Self-Management
A regression model with the DSMQ Glucose Management Subscale, the DSMQ Dietary Control Subscale and the DSMQ Healthcare Use Subscale as explanatory variables fit the DKT2 score data well, R 2 = .057, F(3, 475) = 9.62, p < .001, with DKT2 scores being significantly explained by the DSMQ Glucose Management Subscale, β = .106, 
Diabetes Knowledge and Glycemic Control
No significant correlation was found between DKT2 scores and either HgA1c levels or fasting glucose levels. A median split was performed on DKT2 scores, using 5 as the median. Those who scored 5 or below were labelled poor performers, with those scoring above 5 being labelled high performers. Independent samples t-tests showed no significant differences between high and low performers in HgA1c levels, t(472) = -.126, p = .9; or fasting glucose levels, t(472) = .227, p = .82.
Factorial ANOVAs were also conducted to determine if there was any interaction between type of DM and diabetes knowledge for glucose levels. While a main effect was found for DM type on HgA1c levels, F(1, 470) = 16.231, p < .001, η 2 partial =.033, and on fasting glucose levels, F(1, 470) = 6.622, p = .01, η 2 partial = .014, there was no main effect found for diabetes knowledge, and no significant interaction.
Post-hoc independent samples t-tests confirmed the difference in HgA1c levels between Type 1 (M = 10.067, SD = 2.572) and Type 2 patients (M = 8.535, SD = 2.361), t(490) = 4.492, p < .001; and the difference in fasting glucose levels between Type 1 (M =12.527, SD = 5.53) and Type 2 patients (M = 10.514, SD = 4.574), t(63.641) = 2.59, p = .012. However, because of the difference in sample sizes across the two groups, statistical power is quite low. For this reason, the data have not been split to consider regression models for both groups. Additional independent samples t-tests for MMAS8, DKT2 and DSMQ scores revealed no significant differences between the two patient groups.
Self-Management and Glycemic Control
Based on preliminary correlational results, a regression model was formed with the DSMQ Dietary Control Subscale and age as explanatory variables, and fasting glucose levels as the outcome variable. The model fit the data well, R 2 = .036, F(2, 484) = 9.036, p < .001, with glucose readings being significantly explained by both the DSMQ Dietary Subscale, β = -.091, t(483) = -2.033, p < .05; and age, β = -.158, t(483) = -3.535, p < .001.
The same model also fit the data for HgA1c readings well, R 2 = .064, F(2, 484) = 16.418, p < .001. However, age was the only significant explanatory variable, β = -.24, t(483) = -5.435, p < .001.
Additional Observations
Independent samples t-tests revealed that patients who use oral hypoglycemic agents exclusively reported lower HgA1c levels (M = 8.411, SD = 2.344) than those who do not (M = 9.022, SD = 2.486), t(488) = 2.801, p < .01; and also reported lower glucose fasting levels (M = 10.253, SD = 4.459) than those who do not (M = 11.27, SD = 4.948), t(481.07) = 2.378, p < .05.
In addition, patients who use insulin exclusively as a treatment option reported higher HgA1c levels (M = 9.102, SD = 2.488) than those who do not (M = 8.417, SD = 2.347), t(489) = -3.123, p < .01; and also reported higher glucose fasting levels (M = 11.392, SD = 4.978) than those who do not (M = 10.263, SD = 4.479), t(425.62) = -2.596, p < .05.
Discussion
We set out to examine the interplay between medication adherence, diabetes knowledge, self-management behaviours, and glycemic control in patients with a diagnosis of diabetes mellitus (DM). Our findings suggest a positive association between medication adherence and patient knowledge of diabetes. This provides further support to research which found that patients who were more knowledgeable about their disease adhered more closely to their treatment regimen than those with poor knowledge (Al-Qazaz et al. 2011) . This is in line with self-determination theory (SDT) which considers perceived competency as an integral factor in determining whether or not patients engage in positive health behaviours that would improve their disease outcomes.
Further complimenting SDT is the positive association found between diabetes knowledge and both glucose management and healthcare use behaviours. Our findings suggest that the more knowledge a patient has about his/her disease, the more likely he/she is to engage with the healthcare process by attending regular appointments with their healthcare provider, and manage their glucose levels by taking their prescribed medication and monitoring their blood glucose levels regularly. While there was a positive correlation between the dietary control subscale and diabetes knowledge, dietary control did not emerge as a significant explanatory variable in the regression model. This is perhaps due to the controlling effect of the other subscales in this model. The lack of association between diabetes knowledge and the physical activity subscale may be due to the fact that the DKT2 only contains one question related to physical activity, and therefore may not be a robust enough measure of a patient's knowledge of how physical activity can improve outcomes for diabetic patients.
Our hypothesis that good diabetes knowledge would be associated with good glycemic control was not supported. This is true for both HgA1c and fasting glucose levels. This is in contrast with previous research (Al-Qazaz et al., 2011; Berikai et al., 2007) . A key difference between the present study and previous studies (Berikai et al., 2007) is that they examined blood glucose levels at two time points: before and after receiving diabetes self-management education. They therefore examine the effect that a gain in knowledge has on glycemic control across time. The lack of a significant association here does not imply that such educational initiatives lack merit, but suggests that an increase in knowledge may be a more compelling predictor of glycemic control than knowledge at a single time point.
Our hypothesis that there would be an association between self-management behaviours and glycemic control was partially supported for fasting glucose levels by a regression model including dietary self-management behaviours and age. Scoring high in dietary control behaviours was associated with lower fasting glucose levels, but not with HgA1c levels. It stands to reason that engaging in dietary control behaviours would result in lower blood glucose levels at a particular time point, while not affecting HgA1c levels which are average blood glucose levels across time. It would be interesting to examine this longitudinally, as this would allow for the examination of changes in dietary control behaviours across time. Such an approach may unearth an association with HgA1c levels.
The lack of association between other self-management behaviours and blood glucose levels was more surprising. A key limitation of this study is that participants' behaviour was self-reported and not measured at different time points. Cross-referencing participants' self-reports with those of their caregivers or close family members may give more insight into each patient's relationship with their illness. The fact that age emerged as a significant explanatory variable for both blood glucose readings suggests that older age is associated with better glycemic control. As older patients have generally been living with the disease for longer than younger patients, their treatment plan may have already evolved from the trial and error period, which may result in better glycemic control. It may be interesting for future studies to examine the reasons behind this effect.
Another limitation of the present study is that the sample contains significantly more patients with Type 2 diabetes than Type 1 diabetes. While Type 1 patients had significantly higher glucose levels than Type 2 patients in our sample, the difference in group sizes leads to limited statistical power. Future research with a more balanced sample could examine the regression models presented in sections 3.2, 3.3 and 3.5 to see if they are a good fit for both patient groups.
Conclusion
It is important for healthcare practitioners to ensure DM patients are knowledgeable about their disease. This will allow patients to take a more active role in their healthcare self-management, and may encourage behaviours such as dietary control which could improve their glycemic control. Patients are also more likely to adhere to their prescribed medication plan if they know how taking their medication affects their healthcare outcomes. While it is not clear whether there is an association between diabetes knowledge and glycemic control, it is essential that patients are encouraged to engage in self-management behaviours such as physical activity, glucose management, dietary control, and healthcare use, so that they feel actively engaged in the healthcare process. This process begins with the healthcare practitioner educating the patient on the facts of their illness, their treatment, and optimal outcomes.
